Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer.
Durairaj C, Ruiz-Garcia A, Gauthier ER, Huang X, Lu DR, Hoffman JT, Finn RS, Joy AA, Ettl J, Rugo HS, Zheng J, Wilner KD, Wang DD.
Durairaj C, et al. Among authors: zheng j.
Anticancer Drugs. 2018 Mar;29(3):271-280. doi: 10.1097/CAD.0000000000000589.
Anticancer Drugs. 2018.
PMID: 29360661
Free PMC article.
Clinical Trial.